← Leaderboards
Caroline E Cameron
University Of Victoria
$10,236,423
Attributed
$12,987,359
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,987,359 · 7
By mechanism
R01$5,740,782 · 2
U01$3,194,893 · 1
R37$1,977,404 · 1
U19$1,722,157 · 2
R21$352,123 · 1
Top collaborators
- Sheila A. Lukehart4 shared
- Lorenzo Giacani2 shared
Others in their field
Top investigators on “Syphilis”
- Justin D. Radolf · University Of Connecticut Sch Of Med/Dnt$15,833,446
- Steven Shoptaw · University Of California Los Angeles$15,410,000
- Warren D. Johnson · Weill Medical College Of Cornell Univ$14,499,121
- Steffanie A Strathdee · University Of California, San Diego$14,083,604
- Michael V Norgard · Ut Southwestern Medical Center$12,684,553
- Christina M Marra · University Of Washington$11,926,825
Research focus
SyphilisTreponema PallidumInfectionPathogenInvestigationExhibitsEuropeImmunizationSyphilis VaccineTissuesCongenital SyphilisVaccine CandidateProteinsPreventBacteriaMolecularBacterial AdhesinsPrevalenceExtracellular MatrixImmune ResponseUnited StatesIn VivoFundingOrgan
Grant awards (35)
Development of a Chimeric Syphilis Vaccine Candidate to Combat Local, Disseminated and Congenital Syphilis Infection$1,572,419
U01 · FY2025 · AI · contact PI
Extracellular Matrix Adhesins of Treponema pallidum$306,534
R37 · FY2025 · AI · contact PI
Development of a Direct Diagnostic Test for Infectious and Congenital Syphilis$75,363
R21 · FY2025 · AI · contact PI
Development of a Direct Diagnostic Test for Infectious and Congenital Syphilis$16,000
R21 · FY2025 · AI · contact PI
Development of a Chimeric Syphilis Vaccine Candidate to Combat Local, Disseminated and Congenital Syphilis Infection$1,622,474
U01 · FY2024 · AI · contact PI
Extracellular Matrix Adhesins of Treponema pallidum$316,014
R37 · FY2024 · AI · contact PI
Development of a Direct Diagnostic Test for Infectious and Congenital Syphilis$260,760
R21 · FY2024 · AI · contact PI
Extracellular Matrix Adhesins of Treponema pallidum$263,346
R37 · FY2023 · AI · contact PI
Optimization to Improve the Protective Capacity of the Tp0751 Syphilis Vaccine Candidate$255,832
U19 · FY2023 · AI · contact PI
Optimization to Improve the Protective Capacity of the Tp0751 Syphilis Vaccine Candidate$346,869
U19 · FY2022 · AI · contact PI
Extracellular Matrix Adhesins of Treponema pallidum$267,483
R37 · FY2022 · AI · contact PI
Optimization to Improve the Protective Capacity of the Tp0751 Syphilis Vaccine Candidate$346,695
U19 · FY2021 · AI · contact PI
Extracellular Matrix Adhesins of Treponema pallidum$271,497
R37 · FY2021 · AI · contact PI
Optimization to Improve the Protective Capacity of the Tp0751 Syphilis Vaccine Candidate$444,796
U19 · FY2020 · AI · contact PI
Extracellular Matrix Adhesins of Treponema pallidum$275,394
R37 · FY2020 · AI · contact PI
Innovative approaches to syphilis vaccine design$571,736
R01 · FY2019 · AI
Optimization to Improve the Protective Capacity of the Tp0751 Syphilis Vaccine Candidate$327,965
U19 · FY2019 · AI · contact PI
Extracellular Matrix Adhesins of Treponema pallidum$277,136
R37 · FY2019 · AI · contact PI
Innovative approaches to syphilis vaccine design$604,963
R01 · FY2018 · AI
Innovative approaches to syphilis vaccine design$530,015
R01 · FY2017 · AI
Extracellular Matix Adhesins of Treponema pallidum$232,650
R01 · FY2017 · AI · contact PI
Innovative approaches to syphilis vaccine design$600,266
R01 · FY2016 · AI
Extracellular Matix Adhesins of Treponema pallidum$236,542
R01 · FY2016 · AI · contact PI
Extracellular Matix Adhesins of Treponema pallidum$241,687
R01 · FY2015 · AI · contact PI
Extracellular Matix Adhesins of Treponema pallidum$249,802
R01 · FY2014 · AI · contact PI
Extracellular Matix Adhesins of Treponema pallidum$239,286
R01 · FY2013 · AI · contact PI
Extracellular Matrix Adhesins of Treponema pallidum$233,640
R01 · FY2011 · AI · contact PI
Extracellular Matrix Adhesins of Treponema pallidum$238,422
R01 · FY2010 · AI · contact PI
Extracellular Matrix Adhesins of Treponema pallidum$240,045
R01 · FY2009 · AI · contact PI
Extracellular Matrix Adhesins of Treponema pallidum$239,261
R01 · FY2008 · AI · contact PI
Extracellular Matrix Adhesins of Treponema pallidum$244,327
R01 · FY2007 · AI · contact PI
Extracellular matrix adhesins of Treponema pallidum$260,140
R01 · FY2005 · AI
Extracellular matrix adhesins of Treponema pallidum$260,140
R01 · FY2004 · AI
Extracellular matrix adhesins of Treponema pallidum$260,140
R01 · FY2003 · AI
Extracellular matrix adhesins of Treponema pallidum$257,720
R01 · FY2002 · AI